Favorskii-Type Rearrangement of the 4,5-Epoxymorphinan Skeleton-Reference-Cited by-同舟云学术

Favorskii-Type Rearrangement of the 4,5-Epoxymorphinan Skeleton

Published:2018-03-07 Issue:6 Volume:20 Page:1559-1562
ISSN:1523-7060
Container-title:Organic Letters
language:en
Short-container-title:Org. Lett.

Author:

Kutsumura Noriki¹^ORCID,Koyama Yasuaki²,Suzuki Yuko²,Tominaga Ken-ichi³^ORCID,Yamamoto Naoshi¹,Saitoh Tsuyoshi¹,Nagumo Yasuyuki¹,Nagase Hiroshi¹²^ORCID

Affiliation:

1. International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

2. Graduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8571, Japan

3. National Institute of Advanced Industrial Science and Technology (AIST), Central 5 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.8b00288

Reference31 articles.

1. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

2. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Favorskii Rearrangement (Extend to Rings);Reference Module in Chemistry, Molecular Sciences and Chemical Engineering;2023

2. Synthesis and Applications of Cyclopropanones and Their Equivalents as Three-Carbon Building Blocks in Organic Synthesis;Synthesis;2021-05-27

3. Rearrangement Reactions;Applied Organic Chemistry;2020-12-11

4. A.E.Favorskii’s scientific legacy in modern organic chemistry: prototropic acetylene – allene isomerization and the acetylene zipper reaction;Russian Chemical Reviews;2020-01-01

5. A Novel Rearrangement Reaction of Morphinan to Arylmorphan Skeletons and the Pharmacologies of Arylmorphan Derivatives;HETEROCYCLES;2019